BIOA vs TYL · rev $9.0M vs P/E 89, rev $1.26B
BioAge Labs, Inc (BIOA) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
BIOA currently screens at market cap $697.9M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the BIOA and TYL stock pages for the full models.
Not investment advice.